Pharmacometrics AI

We are a dedicated platform that explores the transformative role of AI in drug development and therapeutic decision-making. This page curates the latest news, insights, and breakthroughs at the intersection of data science and pharmacological sciences. Here, you'll find summaries of our apps and others recently published manuscripts, highlights of innovative apps and tools developed for model-informed drug development, and real-world applications of ML/DL in dose optimization, trial simulation,[1][2]

Overview

Pharmacometrics AI is a healthcare AI company operating in the New York City artificial intelligence scene[1]. The platform focuses on the intersection of data science and pharmacological sciences, curating news, insights, and breakthroughs in AI applications for drug development and therapeutic decision-making[2]. The company develops apps and tools for model-informed drug development, with applications in dose optimization and trial simulation using machine learning and deep learning approaches[2]. According to available professional profiles, the company operates with approximately four employees[3] and is categorized within the data infrastructure and analytics sector[3].

Growth & traction

LinkedIn lists 4 people working at Pharmacometrics AI. [4]

Key people

Focus

  • Pharmacometrics AI describes itself as "AI platform focused on sharing and building tools brick by brick for analysts to tackle all aspects of pharmacometrics.".[5]

Something wrong or missing? Send an update. Fixed within 24 hours.